Pardes Biosciences, Inc.
PRDSDelisted Aug 31, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822711
Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Pardes Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 64 | 60 | −4 |
| Shares | 37.8M | 36.8M | −938.0K (−2.5%) |
| Value | $63.8M | $48.6M | −$15.2M (−23.8%) |
New holders (3)
Institutions that held Pardes Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 15,846 | $20.9K | 0.00% |
| Creative Planning | 10,000 | $13.2K | 0.00% |
| State of Wyoming | 201 | $265 | 0.00% |
Sold out (7)
Institutions that held Pardes Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Walleye Capital LLC | 266,782 | $450.9K |
| Franklin Resources Inc | 180,631 | $305.3K |
| Oasis Management Co Ltd. | 175,000 | $295.8K |
| Jane Street Group, LLC | 21,473 | $36.3K |
| Tri Locum Partners LP | 19,757 | $33.0K |
| Chicago Partners Investment Group LLC | 11,316 | $21.3K |
| Credit Suisse AG | 1 | $2 |